Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
3.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
Bone Disorders01:29

Bone Disorders

8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

56
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Succinate mediates inflammation-induced adrenocortical dysfunction.

eLife·2023
Same author

Activation of β-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male mice.

American journal of physiology. Endocrinology and metabolism·2023
Same author

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.

Frontiers in endocrinology·2022
Same author

Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity.

Bone research·2021
Same author

The Role of Glucocorticoids in the Management of COVID-19.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2020
Same author

Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.

Molecular metabolism·2020

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

1.1K

Glucocorticoids and bone: local effects and systemic implications.

Holger Henneicke1, Sylvia J Gasparini1, Tara C Brennan-Speranza1

  • 1Bone Research Program, The Australian and New Zealand Army Corps (ANZAC) Research Institute, The University of Sydney, Sydney, Australia.

Trends in Endocrinology and Metabolism: TEM
|January 15, 2014
PubMed
Summary

Glucocorticoids (GCs) effectively treat inflammation but cause osteoporosis and metabolic issues. New research links GC effects on bone cells and osteocalcin to these adverse outcomes, offering prevention strategies.

Keywords:
bonediabetesglucocorticoidsosteoporosispathophysiologyphysiology

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.1K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

23.6K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

1.1K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.1K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

23.6K

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Bone Biology

Background:

  • Glucocorticoids (GCs) are vital for treating inflammatory and autoimmune diseases.
  • Therapeutic use of GCs is restricted by significant adverse effects.
  • GCs impact bone health and energy metabolism, leading to osteoporosis, diabetes, and obesity.

Purpose of the Study:

  • To review the physiological and pathophysiological actions of GCs on bone cells.
  • To discuss molecular mechanisms underlying GC-induced osteoporosis and metabolic dysfunction.
  • To explore novel strategies for preventing and treating GC-induced adverse effects.

Main Methods:

  • Review of current literature on glucocorticoid action in bone and metabolism.
  • Analysis of molecular pathways involved in GC-induced bone loss and metabolic changes.
  • Integration of findings on osteocalcin's role in GC pathophysiology.

Main Results:

  • GCs exert detrimental effects on bone cells, contributing to osteoporosis.
  • Osteocalcin, an osteoblast-derived peptide, is implicated in GC-induced diabetes and obesity.
  • A mechanistic link exists between GC actions on bone and energy metabolism.

Conclusions:

  • Understanding GC mechanisms on bone cells is crucial for developing targeted therapies.
  • Strategies targeting osteocalcin may mitigate GC-induced metabolic adverse effects.
  • Integrated approaches are needed to manage the dual impact of GCs on bone and metabolism.